Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 7/20 | 0.83 |
| ▸ | KLK7 | P49862 | 1/20 | 0.83 |
| ▸ | MEN1 | O00255 | 6/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.74 |
| ▸ | MAPT | P10636 | 6/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.74 |
| ▸ | TP53 | P04637 | 4/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.74 |
| ▸ | MAOA | P21397 | 4/20 | 0.74 |
| ▸ | MAOB | P27338 | 4/20 | 0.74 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.74 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.74 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.74 |
| ▸ | HPGD | P15428 | 3/20 | 0.74 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.74 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.74 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.74 |
| ▸ | BCL2 | P10415 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29448332 | 0.91 | RAB9A (0.90) | RAB9AKLK7MEN1KMT2AMAPT | |
| Castanin SCHEMBL572274 | 0.91 | RAB9A (1.00) | RAB9AKLK7MEN1KMT2AMAPT | |
| SCHEMBL13169484 | 0.89 | RAB9A (0.74) | RAB9AKLK7MEN1KMT2AMAPT | |
| Formononetin SCHEMBL62915 | 0.85 | KDM4E (1.00) | RAB9AKLK7MEN1KMT2AMAPT | |
| Formononetin SCHEMBL15271536 | 0.85 | KDM4E (1.00) | RAB9AKLK7MEN1KMT2AMAPT | |
| Formononetin SCHEMBL29361145 | 0.85 | KDM4E (1.00) | RAB9AKLK7MEN1KMT2AMAPT | |
| SCHEMBL30573375 | 0.84 | RAB9A (0.81) | RAB9AKLK7MEN1KMT2AMAPT | |
| SCHEMBL7030328 | 0.84 | RAB9A (0.81) | RAB9AKLK7MEN1KMT2AMAPT | |
| SCHEMBL28495484 | 0.84 | RAB9A (0.65) | RAB9AKLK7MEN1KMT2AMAPT | |
| SCHEMBL571576 | 0.84 | XDH (0.84) | RAB9AKLK7MEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230293565-A1 | USE OF WNT/BETA-CATENIN PATHWAY INHIBITORS TO BLOCK REPLICATION OF SARS-COV-2 AND OTHER PATHOGENIC VIRUSES | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2023-09-21 | — | — | US | claimed |
| CN-113130001-B | Screening method for compatibility of natural compound and anti-tumor compound | 甘肃中医药大学 | 2023-07-18 | — | — | CN | claimed |
| CN-116249520-A | Blocking replication of SARS-COV-2 and other pathogenic viruses using WNT/beta-catenin pathway inhibitors | 阿尔伯塔大学理事会 | 2023-06-09 | — | — | CN | claimed |
| EP-4188378-A1 | USE OF WNT/BETA-CATENIN PATHWAY INHIBITORS TO BLOCK REPLICATION OF SARS-COV-2 AND OTHER PATHOGENIC VIRUSES | The Governors of the University of Alberta (CA) | 2023-06-07 | — | — | EP | claimed |
| CN-114115182-A | Motor controller test system and method | 中国商用飞机有限责任公司北京民用飞机技术研究中心 | 2022-03-01 | — | — | CN | claimed |
| WO-2022020967-A1 | USE OF WNT/BETA-CATENIN PATHWAY INHIBITORS TO BLOCK REPLICATION OF SARS-COV-2 AND OTHER PATHOGENIC VIRUSES | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2022-02-03 | — | — | WO | claimed |
| US-20260034152-A1 | Influx Vitamins and Drinks, with Zinc Ionophoric Influx | BLACK STEPHEN (US) | 2026-02-05 | — | — | US | disclosed |
| US-20250367337-A1 | OZONE SPRAY METHODS | SEEGROW SOLUTIONS LTD (GB) | 2025-12-04 | — | — | US | disclosed |
| WO-2025087805-A1 | PRESSURE MEASURING DEVICE | Ph-Instruments GmbH (AT) | 2025-05-01 | — | — | WO | disclosed |
| CN-116283873-B | Preparation method of kyunonin and application of kyunonin in resisting ischemic cerebral apoplexy and Alzheimer's disease | 扬州大学 | 2025-02-21 | — | — | CN | disclosed |
| US-20250008868-A1 | VALVED DOSING SYSTEM | SEEGROW HOLDINGS LIMITED (GB) | 2025-01-09 | — | — | US | disclosed |
| WO-2024225151-A1 | LEGUME-DERIVED COMPOSITION AND METHOD FOR PRODUCING SAME, AND CHICKEN GIZZARD-DERIVED COMPOSITION AND METHOD FOR PRODUCING SAME | サントリーホールディングス株式会社 | 2024-10-31 | — | — | WO | disclosed |
| US-12116964-B2 | Dewatering fuel in a diesel locomotive | Siemens Mobility GmbH (DE) | 2024-10-15 | — | — | US | disclosed |
| US-4390559-A | AND EDIBLE FAT OR OIL | Z-L LIMITED PARTNERSHIP (US) | 1983-06-28 | — | — | US | disclosed |
| US-4366082-A | Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same | Z-L LIMITED PARTNERSHIP (US) | 1982-12-28 | — | — | US | disclosed |
| US-4366248-A | USING SOYBEANS WITH THE FUNGUS RHIZOPUS | Z-L LIMITED PARTNERSHIP (US) | 1982-12-28 | — | — | US | disclosed |
| EP-0027796-A4 | CHROMAN AND CHROMANON-4 DERIVATIVES, PROCESS FOR THEIR PREPARATION, ANTIOXIDANT COMPOSITIONS CONTAINING SAME AND THEIR USE FOR STABILIZING EDIBLE FATS AND OILS. | Z L LTD PARTNERSHIP (US) | 1981-08-31 | — | — | EP | disclosed |
| EP-0027796-A1 | CHROMAN AND CHROMANON-4 DERIVATIVES, PROCESS FOR THEIR PREPARATION, ANTIOXIDANT COMPOSITIONS CONTAINING SAME AND THEIR USE FOR STABILIZING EDIBLE FATS AND OILS. | Z L LTD PARTNERSHIP (US) | 1981-05-06 | — | — | EP | disclosed |
| US-4264509-A | STORAGE STABILITY FOR FOODS CONTAINING OILS AND FATS | Z-L LIMITED PARTNERSHIP (US) | 1981-04-28 | — | — | US | disclosed |
| WO-1980002098-A1 | ISOFLAVONES AND RELATED COMPOUNDS,METHODS OF PREPARING AND USING AND ANTIOXIDANT COMPOSITIONS CONTAINING SAME | PARTNERSHIP LTD (US) | 1980-10-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034152-A1 | Influx Vitamins and Drinks, with Zinc Ionophoric Influx | KCNN3, VDR, KCNN2 | RAB9A 2350/4885KLK7 1122/4885MEN1 2709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.